Kadcyla, a drug that can offer some women with advanced breast cancer nearly six months of extra life, which was trialled here in the North East, has for now been rejected for use in the NHS, because of its high cost.
A Newcastle doctor whose patients have been involved in the clinical trials is disappointed by the decision.
Dr Mark Verrill, from the Freeman Hospital, say the drug is revolutionary.
More top news
Health services that dealt with a double murderer should have identified the probability that he would re-offend
The Sunderland boss Dick Advocaat has tonight left the club.
Plans are underway to transform Auckland Castle into a major tourist destination with the help of a £10 million grant.